Physician profile
Matthew Baron
NPI 1487074142
$4,018.74
in general payments reported to CMS, 2019-2025
12 companies · $40.80 in 2025
The $40.80 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $881 · 2020: $59.01 · 2022: $555 · 2023: $1,566 · 2024: $917 · 2025: $40.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,100 · Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,100.00 |
| Food and Beverage | $423.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $2,100.00 | 2023-2024 | |
| Stryker Corporation | $988.47 | 2019-2023 | Sps |
| Depuy Synthes Sales INC. | $303.26 | 2022-2023 | Va-Lcp, Tfn-Advance |
| Smith+Nephew, INC. | $271.29 | 2019-2024 | Evos |
| Curvafix, INC. | $127.63 | 2022 | |
| Medical Device Business Services, INC. | $59.01 | 2020 | |
| Illuminoss Medical, INC. | $43.94 | 2022 | |
| Merck Sharp & Dohme LLC | $41.04 | 2024-2025 | Bridion |
| Zimmer Biomet Holdings, INC. | $24.80 | 2022 | |
| Abbott Laboratories | $22.72 | 2024 | Eterna |
| Heron Therapeutics, INC. | $19.36 | 2025 | Aponvie |
| Glaxosmithkline, LLC. | $17.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Baron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.